Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2386 AL 2400

Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics

Nairuz T, Sangwoo-Cho, Lee JH.

Cells. 2024 Jun 3;13(11):966. doi: 10.3390/cells13110966.

Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology

Currim F, Tanwar R, Brown-Leung JM, Paranjape N, Liu J, Sanders LH, Doorn JA, Cannon JR.

Neurotoxicology. 2024 Jul;103:266-287. doi: 10.1016/j.neuro.2024.06.016. Epub 2024 Jul 2.

Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies

Moes HR, Dafsari HS, Jost WH, Kovacs N, Pirtošek Z, Henriksen T, Falup-Pecurariu C, Minár M, Buskens E, van Laar T.

J Neural Transm (Vienna). 2024 Nov;131(11):1295-1305. doi: 10.1007/s00702-024-02783-1. Epub 2024 Jul 15.

Therapeutic potential of Parkin and its regulation in Parkinson's disease

Safreena N, Nair IC, Chandra G.

Biochem Pharmacol. 2024 Dec;230(Pt 3):116600. doi: 10.1016/j.bcp.2024.116600. Epub 2024 Nov 3.

Effect of Levodopa on Heat Hypersensitivity and Complex Motor Parkinsonism

Noyes E, Rajput AH, Bocking S, Rajput A.

Clin Neuropharmacol. 2024 Jan-Feb 01;47(1):29-32. doi: 10.1097/WNF.0000000000000580. Epub 2023 Dec 27.

Neuroplasticity in levodopa-induced dyskinesias: An overview on pathophysiology and therapeutic targets

Bove F, Angeloni B, Sanginario P, Rossini PM, Calabresi P, Di Iorio R.

Prog Neurobiol. 2024 Jan;232:102548. doi: 10.1016/j.pneurobio.2023.102548. Epub 2023 Nov 30.

Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases

Velikic G, Maric DM, Maric DL, Supic G, Puletic M, Dulic O, Vojvodic D.

Int J Mol Sci. 2024 Jan 12;25(2):993. doi: 10.3390/ijms25020993.

Photobiomodulation for Neurodegenerative Diseases: A Scoping Review

Shen Q, Guo H, Yan Y.

Int J Mol Sci. 2024 Jan 28;25(3):1625. doi: 10.3390/ijms25031625.

Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit

Alharbi B, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Alharbi H, Alexiou A, Papadakis M, Batiha GE.

Eur J Med Res. 2024 Mar 27;29(1):205. doi: 10.1186/s40001-024-01779-7.

Mapping the Research of Ferroptosis in Parkinson's Disease from 2013 to 2023: A Scientometric Review

Chen Y, Wu Z, Li S, Chen Q, Wang L, Qi X, Tian C, Yang M.

Drug Des Devel Ther. 2024 Apr 3;18:1053-1081. doi: 10.2147/DDDT.S458026. eCollection 2024.

The gut microbiota-brain axis in neurological disorders

You M, Chen N, Yang Y, Cheng L, He H, Cai Y, Liu Y, Liu H, Hong G.

MedComm (2020). 2024 Jul 20;5(8):e656. doi: 10.1002/mco2.656. eCollection 2024 Aug.

Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi Is a Promising Candidate for the Treatment of Cancer, Alzheimer's Disease, and Obesity

Bartkowiak-Wieczorek J, Malesza M, Malesza I, Hadada T, Winkler-Galicki J, Grzelak T, Mądry E.

Nutrients. 2024 Aug 1;16(15):2509. doi: 10.3390/nu16152509.

The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases

Coretti L, Buommino E, Lembo F.

Front Cell Neurosci. 2024 Aug 8;18:1433747. doi: 10.3389/fncel.2024.1433747. eCollection 2024.

Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research

Shoemaker RL, Larsen RJ, Larsen PA.

Front Immunol. 2024 Aug 22;15:1426656. doi: 10.3389/fimmu.2024.1426656. eCollection 2024.

Dysbiosis and fecal microbiota transplant: Contemplating progress in health, neurodegeneration and longevity

Ahmadi S, Hasani A, Khabbaz A, Poortahmasbe V, Hosseini S, Yasdchi M, Mehdizadehfar E, Mousavi Z, Hasani R, Nabizadeh E, Nezhadi J.

Biogerontology. 2024 Nov;25(6):957-983. doi: 10.1007/s10522-024-10136-4. Epub 2024 Sep 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias